• 100+

    The UK’s most active investor in UK university spin-outs

  • £250M

    Over £250m raised; invested into over 100 companies

  • 16 wins

    Award winning manager with track record of delivering returns

  • £1.1Bn

    Part of FTSE 250 sector specialist group with £1.1bn net assets

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.
Covid-19 Update: We continue to operate as usual, supporting the best of our technology companies. We accept applications by email and are having video updates with investors and advisers. Further details here.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Chloe Richardson
Moray Wright
Tom Hopkins
Meet the team

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

QKine

QKine spun-out from the  University of Cambridge in 2016. The company manufactures high quality growth factors and cytokines for stem cell, organoid and regenerative medicine applications. QKine uses proprietary protein purification and engineering technology to make recombinant proteins in E.coli. 

Sphere Medical

Sphere Medical is a dynamic medtech company currently developing a series of innovative critical care devices from its sterile, miniaturised, electrochemical sensor technology platform. The first product, Proxima, is the only patient-connected, continuous blood gas analyser offering vital clinical information quicker, more frequently, and at the bedside providing efficiencies that result in reduce

Proxisense

Proxisense specialises in advanced sensors, diagnostics and optimisation systems using proprietary eddy current technology and custom algorithms to provide highly accurate positioning data for extreme and inaccessible mechanical environments. The technology predicts and prevents downtime and equipment failure, improves performance and efficiency of complex equipment and predicts potential failures

View Portfolio